Boc Hong Kong (OTCMKTS:BHKLY) Upgraded at Goldman Sachs Group

Share on StockTwits

Boc Hong Kong (OTCMKTS:BHKLY) was upgraded by research analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, The Fly reports.

Several other analysts have also recently weighed in on BHKLY. Citigroup cut shares of Boc Hong Kong from a “buy” rating to a “neutral” rating in a report on Thursday, August 8th. ValuEngine upgraded shares of Boc Hong Kong from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd.

Shares of Boc Hong Kong stock traded up $1.21 during trading on Tuesday, reaching $67.70. 7,044 shares of the company traded hands, compared to its average volume of 17,383. The company has a 50 day moving average price of $68.22 and a 200-day moving average price of $77.19. Boc Hong Kong has a 1-year low of $64.20 and a 1-year high of $91.79.

About Boc Hong Kong

BOC Hong Kong (Holdings) Limited, an investment holding company, provides banking and related financial services to corporate and individual customers in Hong Kong, Mainland China, and internationally. It operates through four segments: Personal Banking, Corporate Banking, Treasury, and Insurance. The company offers savings, current, and time deposit accounts; mortgage plans; overdrafts; personal loans; personal life, medical and accident, travel and leisure, business protection, home, domestic helper, motor, and golfer insurance products; wealth management services; and Internet, phone, and mobile banking services.

Recommended Story: How to invest in a bear market

The Fly

Receive News & Ratings for Boc Hong Kong Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boc Hong Kong and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

LPL Financial  Hits New 12-Month High at $91.54
LPL Financial Hits New 12-Month High at $91.54
Campbell Soup  Sets New 12-Month High at $48.39
Campbell Soup Sets New 12-Month High at $48.39
L Brands  Hits New 12-Month Low at $15.80
L Brands Hits New 12-Month Low at $15.80
Evoke Pharma  Shares Gap Down to $1.33
Evoke Pharma Shares Gap Down to $1.33
Biglari Holdings Inc  CEO Sardar Biglari Buys 100 Shares
Biglari Holdings Inc CEO Sardar Biglari Buys 100 Shares
Zacks Investment Research Lowers Hikma Pharmaceuticals  to Hold
Zacks Investment Research Lowers Hikma Pharmaceuticals to Hold


© 2006-2019 Ticker Report